Innoviz (INVZ) Chief R&D Officer Avishay Moscovici Receives RSU/Option Awards

What Happened
Avishay Moscovici, Chief R&D Officer of Innoviz Technologies Ltd. (INVZ), received equity awards on August 4, 2026: 66,336 Restricted Share Units (RSUs) and 71,072 derivative awards (stock options/award units). Both awards were granted with no cash outlay (reported price $0.00). The RSUs and the derivative awards vest over time rather than being immediately tradable.

Key Details

• Transaction date: August 4, 2026; filing date: August 5, 2026. Reported as Award/Grant (code A).
• Grant details:
  • 66,336 RSUs (F1): one-fourth vest on August 4, 2027; remaining shares vest quarterly through 2030.
  • 71,072 derivative awards (F4): one-fourth vest on August 4, 2027; remainder vest quarterly through 2030.
• Price: reported $0.00 for both entries (RSUs have no exercise price; awards are compensation grants).
• Shares issuable after grant: filing notes a total of 213,724 ordinary shares issuable upon vesting of outstanding RSUs (see F2 for breakdown by grant year).
• Vesting condition: all awards vest only if Moscovici remains a service provider of Innoviz on each applicable vesting date (F3).
• Filing timeliness: reported the day after the grants (Aug 5 filing for Aug 4 transactions); no late-report indication provided.

Context

• RSUs: each RSU is a contingent right to receive one ordinary share upon vesting; no immediate purchase or sale occurred.
• Derivative awards/options: these vest over time per the same schedule; the filing does not indicate immediate exercise or sale.
• For retail investors: grants are compensation/retention awards and are common for executives; they do not represent an immediate change in market share count until vesting and issuance.